Dr. Hamilton is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2115 Wisconsin Ave NW
Ste 200
Washington, DC 20007Phone+1 202-944-5400
Summary
- Kelly Hamilton, DO, is a resident psychiatrist located in Washington, DC. He completed her education at Rowan University School of Osteopathic Medicine, graduating in 2022, and will complete his psychiatry residency at MedStar Health/Georgetown University Hospital in 2026. Prior to his medical education, he gained experience as an Army paramedic. Dr. Hamilton has contributed to several publications, including research on educational methods for medical students and studies on Maackia amurensis seed lectin's effects, particularly concerning COVID-19 and oral squamous cell carcinoma. His work has been cited by others multiple times across different publications.
Education & Training
MedStar Health/Georgetown University HospitalResidency, Psychiatry, 2022- Rowan University School of Osteopathic MedicineClass of 2022
Certifications & Licensure
DC State License 2022 - 2025
VA State License 2022 - 2025
Publications & Presentations
PubMed
- 1 citationsVideo Didactic Preparation Augments Problem-Based Learning for First Year Medical Students.Kelly L Hamilton, Yu-Chun Kuo, Peter Horneffer, T Peter Stein, Gary S Goldberg
Journal of Medical Education and Curricular Development. 2023-05-29 - 2 citationsMaackia amurensis seed lectin (MASL) ameliorates articular cartilage destruction and increases movement velocity of mice with TNFα induced rheumatoid arthritis.Kelly L Hamilton, Amanda A Greenspan, Alan J Shienbaum, Bradford D Fischer, Andrea Bottaro
Biochemistry and Biophysics Reports. 2022-12-01 - 9 citationsEvidence that Maackia amurensis seed lectin (MASL) exerts pleiotropic actions on oral squamous cells with potential to inhibit SARS-CoV-2 infection and COVID-19 diseas...Stephanie A. Sheehan, Kelly L. Hamilton, Edward P. Retzbach, Premalatha Balachandran, Harini Krishnan
Experimental Cell Research. 2021-06-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
